Literature DB >> 32269021

Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.

David N Juurlink1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32269021      PMCID： PMC7207200          DOI： 10.1503/cmaj.200528

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  50 in total

1.  Chloroquine-induced psychiatric complications.

Authors:  M S Bhatia
Journal:  Br J Psychiatry       Date:  1991-11       Impact factor: 9.319

2.  Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature.

Authors:  Clotilde Chatre; François Roubille; Hélène Vernhet; Christian Jorgensen; Yves-Marie Pers
Journal:  Drug Saf       Date:  2018-10       Impact factor: 5.606

3.  Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.

Authors:  Jianjun Gao; Zhenxue Tian; Xu Yang
Journal:  Biosci Trends       Date:  2020-02-19       Impact factor: 2.400

4.  Influence of hydroxychloroquine on the bioavailability of oral metoprolol.

Authors:  M Somer; J Kallio; U Pesonen; K Pyykkö; R Huupponen; M Scheinin
Journal:  Br J Clin Pharmacol       Date:  2000-06       Impact factor: 4.335

5.  Hydroxychloroquine-induced fatal toxic epidermal necrolysis complicated by angioinvasive rhizopus.

Authors:  Michael C Cameron; Andrew P Word; Arturo Dominguez
Journal:  Dermatol Online J       Date:  2014-11-15

6.  Pregnancy outcome following gestational exposure to azithromycin.

Authors:  Moumita Sarkar; Cindy Woodland; Gideon Koren; Adrienne R N Einarson
Journal:  BMC Pregnancy Childbirth       Date:  2006-05-30       Impact factor: 3.007

7.  Prolonged neuropsychiatric effects following management of chloroquine intoxication with psychotropic polypharmacy.

Authors:  Nicole M Maxwell; Remington L Nevin; Stephen Stahl; Jerald Block; Sarah Shugarts; Alan H B Wu; Stephen Dominy; Miguel Alonso Solano-Blanco; Sharon Kappelman-Culver; Christopher Lee-Messer; Jose Maldonado; Andrew J Maxwell
Journal:  Clin Case Rep       Date:  2015-04-09

8.  Psychosis consequent to antimalarial drug use in a young child.

Authors:  Jitender Aneja; Dheeraj Goya; Bharat Choudhary
Journal:  J Family Med Prim Care       Date:  2019-05

9.  Could Chloroquine /Hydroxychloroquine Be Harmful in Coronavirus Disease 2019 (COVID-19) Treatment?

Authors:  Maurizio Guastalegname; Alfredo Vallone
Journal:  Clin Infect Dis       Date:  2020-07-28       Impact factor: 9.079

10.  In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).

Authors:  Xueting Yao; Fei Ye; Miao Zhang; Cheng Cui; Baoying Huang; Peihua Niu; Xu Liu; Li Zhao; Erdan Dong; Chunli Song; Siyan Zhan; Roujian Lu; Haiyan Li; Wenjie Tan; Dongyang Liu
Journal:  Clin Infect Dis       Date:  2020-07-28       Impact factor: 9.079
View more
  72 in total

1.  Perspectives on repositioning chloroquine and hydroxychloroquine for the treatment of Covid-19.

Authors:  Ahmed Awad Adeel
Journal:  Sudan J Paediatr       Date:  2020

Review 2.  Familiar dermatologic drugs as therapies for COVID-19.

Authors:  M Ortega-Peña; R González-Cuevas
Journal:  Actas Dermosifiliogr       Date:  2020-12-23

3.  Additional safety consideration for azithromycin in the management of SARS-CoV-2 infection.

Authors:  Matthew D Seftel
Journal:  CMAJ       Date:  2020-05-04       Impact factor: 8.262

4.  Chronic myeloid leukaemia and the use of tyrosine kinase inhibitors in the days of COVID-19 pandemic.

Authors:  Ahmet Emre Eşkazan
Journal:  Br J Clin Pharmacol       Date:  2020-05-20       Impact factor: 4.335

5.  Clinical trials for COVID-19 should include sex as a variable.

Authors:  Evelyne Bischof; Jeannette Wolfe; Sabra L Klein
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

6.  Outcomes and clinical practice in patients with COVID-19 admitted to the intensive care unit in Montréal, Canada: a descriptive analysis.

Authors:  Stephen Su Yang; Jed Lipes; Sandra Dial; Blair Schwartz; Denny Laporta; Evan Wong; Craig Baldry; Paul Warshawsky; Patricia McMillan; David Hornstein; Michel de Marchie; Dev Jayaraman
Journal:  CMAJ Open       Date:  2020-11-24

7.  Hydroxychloroquine against COVID-19: A critical appraisal of the existing evidence.

Authors:  Konstantinos Tselios; Panagiotis Skendros
Journal:  Eur J Rheumatol       Date:  2020-05-15

Review 8.  Efficacy and safety of chloroquine and hydroxychloroquine for treatment of COVID-19 patients-a systematic review and meta-analysis of randomized controlled trials.

Authors:  Paul Eze; Kenechukwu N Mezue; Chidozie U Nduka; Ijeoma Obianyo; Obiora Egbuche
Journal:  Am J Cardiovasc Dis       Date:  2021-02-15

9.  Opioid Use Disorder and COVID-19: Biological Plausibility for Worsened Outcomes.

Authors:  Jonathan Schimmel; Alex F Manini
Journal:  Subst Use Misuse       Date:  2020-07-12       Impact factor: 2.164

Review 10.  Metabolism and Interactions of Chloroquine and Hydroxychloroquine with Human Cytochrome P450 Enzymes and Drug Transporters.

Authors:  Slobodan Rendic; Frederick Peter Guengerich
Journal:  Curr Drug Metab       Date:  2020       Impact factor: 3.731
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.